Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Q
317690
vs
K
KOSPI 200
Over the past 12 months, QuantaMatrix Inc has underperformed KOSPI 200, delivering a return of -51% compared to KOSPI 200's +119% growth.
Stocks Performance
317690 vs KOSPI 200
Performance Gap
317690 vs KOSPI 200
Performance By Year
317690 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
QuantaMatrix Inc
Glance View
QuantaMatrix Inc. makes tools that help laboratories identify microorganisms and measure how they respond to antibiotics. Its core products are diagnostic instruments, test cards, and related software used to speed up microbial identification and antibiotic susceptibility testing, which are key steps in diagnosing infections and choosing the right treatment. The company sells mainly to hospitals, clinical laboratories, and other healthcare testing users. It makes money by selling instruments and the consumable test cards that run on those instruments, plus related service and support revenue. That consumable model matters because labs need a steady supply of test cards after they install the system. What sets QuantaMatrix apart is its role in the infection-testing workflow. Instead of being a general medical device maker, it focuses on a specific lab problem: helping clinicians get faster, more precise information about bacteria and antibiotic resistance. That puts it in the healthcare diagnostics supply chain, between the lab sample and the treatment decision.